[ Price : $8.95]
In an unprecedented LinkedIn post, CDER director George Tidmarsh questions the use of surrogate endpoints and publicly attacks Aur...[ Price : $8.95]
The CDER Quantitative Medicine Center of Excellence issues a report on goals and accomplishments in the first 16 months of its exi...[ Price : $8.95]
An HHS contingency plan says FDA would experience sharp reductions in operations if Congress fails to reach a deal to fund the gov...[ Price : $8.95]
FDA posts an International Council for Harmonization draft guideline entitled E20 Adaptive Designs for Clinical Trials that provid...[ Price : $8.95]
FDA issues an updated alert about an ongoing Class 1 recall of certain BD Alaris Pump Module infusion sets due to device performan...[ Price : $8.95]
FDA commissioner Marty Makary tells agency employees that they are protected from planned mass workforce firings if a government s...[ Price : $8.95]
FDA posts a draft guidance to help drugmakers design clinical trials for treatments targeting disseminated coccidioidomycosis, als...[ Price : $8.95]
Larimar Therapeutics reports encouraging long-term data from its open-label study of nomlabofusp, an investigational therapy for F...